MSM
Research MSM (MSM.WA) on Bullrun: market cap PLN 12.94M, P/E 24.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMSM.WA
- ExchangeXNCO
- CountryPoland
- SectorHealthcare
- IndustryMedical Devices
- CurrencyPLN
- Market capPLN 12.94M
- P/E24.8
- Financial periodQ2 2026
- RevenuePLN 7.31M
- Net income-PLN 80.45K
- Free cash flowPLN 48.48K
- Gross margin41.1%
Valuation Snapshot
latest market cap is PLN 12.94M; P/E is 24.8.
Peer valuation comparison
Latest P/E is 24.76x versus a Healthcare sector median of 24.61x.
Latest P/E is 24.76x versus a Poland median of 12.32x (101.1% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-10 | PLN 12.94M | 24.8 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 PLN.
About MSM
Massmedica S.A. engages in the distribution of implants and other medical materials used in the treatment of musculoskeletal system diseases, aesthetic and regenerative medicines in Poland. It provides products in the field of reconstructive, regenerative, anti-aging, and aesthetic medicine. The company's products include supplements, skin care, sun protection, creams, tools, serum, masks, carboxytheraphy, and intra-articular injections.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is MSM's market cap?
MSM's market capitalization is PLN 12.94M.
What is MSM's P/E ratio?
MSM's price-to-earnings (P/E) ratio is 24.8.
What does MSM do?
Massmedica S.A. engages in the distribution of implants and other medical materials used in the treatment of musculoskeletal system diseases, aesthetic and regenerative medicines in Poland. It provides products in the field of reconstructive, regenerative, anti-aging, and aesthetic medicine. The company's products include supplements, skin care, sun protection, creams, tools, serum, masks, carboxytheraphy, and intra-articular injections.